Huntington National Bank’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11 | Hold |
1
| – | – | ﹤0.01% | 3745 |
|
|
2025
Q4 | $11 | Hold |
1
| – | – | ﹤0.01% | 3652 |
|
|
2025
Q3 | $11 | Hold |
1
| – | – | ﹤0.01% | 3683 |
|
|
2025
Q2 | $11 | Hold |
1
| – | – | ﹤0.01% | 3688 |
|
|
2025
Q1 | $11 | Hold |
1
| – | – | ﹤0.01% | 3706 |
|
|
2024
Q4 | $11 | Hold |
1
| – | – | ﹤0.01% | 3706 |
|
|
2024
Q3 | $11 | Hold |
1
| – | – | ﹤0.01% | 3704 |
|
|
2024
Q2 | $11 | Hold |
1
| – | – | ﹤0.01% | 3661 |
|
|
2024
Q1 | $11 | Hold |
1
| – | – | ﹤0.01% | 3526 |
|
|
2023
Q4 | $11 | Hold |
1
| – | – | ﹤0.01% | 3429 |
|
|
2023
Q3 | $11 | Hold |
1
| – | – | ﹤0.01% | 3395 |
|
|
2023
Q2 | $11 | Hold |
1
| – | – | ﹤0.01% | 3364 |
|
|
2023
Q1 | $11 | Sell |
1
-895
| -100% | -$9.85K | ﹤0.01% | 3215 |
|
|
2022
Q4 | $10K | Buy |
896
+83
| +10% | +$804 | ﹤0.01% | 1490 |
|
|
2022
Q3 | $5K | Sell |
813
-324
| -28% | -$2.03K | ﹤0.01% | 1730 |
|
|
2022
Q2 | $5K | Buy |
1,137
+999
| +724% | +$5.68K | ﹤0.01% | 1752 |
|
|
2022
Q1 | $2K | Buy |
138
+15
| +12% | +$179 | ﹤0.01% | 1935 |
|
|
2021
Q4 | $2K | Buy |
+123
| New | +$1.56K | ﹤0.01% | 1926 |
|
Huntington National Bank's OYST Position: Q1 2026 in Review
Huntington National Bank held its Oyster Point Pharma, Inc. Common Stock (OYST) position steady in Q1 2026 at 1 share worth $11. The position accounts for ﹤0.01% of the portfolio, ranked #3745.
Huntington National Bank first reported a position in OYST in Q4 2021 and has held it in 18 quarters since. The position peaked at $10K in Q4 2022. 1 fund tracked by Wall St. Rank holds OYST as of Q1 2026.
- Huntington National Bank held 1 share of Oyster Point Pharma, Inc. Common Stock worth $11 as of Q1 2026.
- Huntington National Bank left its Oyster Point Pharma, Inc. Common Stock share count unchanged in Q1 2026.
- Oyster Point Pharma, Inc. Common Stock made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #3745 holding.
- Huntington National Bank first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2021 and has held it in 18 quarters since.
- Huntington National Bank's Oyster Point Pharma, Inc. Common Stock position peaked at $10K in Q4 2022.
- 1 fund tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2026.
Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.